USANA Health Sciences, Inc. (USNA)
After hours:
| Previous Close | 44.23 |
| Open | 44.44 |
| Bid | 43.30 x 1000 |
| Ask | 48.20 x 1000 |
| Day's Range | 44.44 - 44.99 |
| 52 Week Range | 42.59 - 69.60 |
| Volume | |
| Avg. Volume | 84,617 |
| Market Cap | 861.012M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | 13.56 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
USANA Schedules First Quarter 2024 Earnings Release and Conference Call
SALT LAKE CITY, April 10, 2024--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institut
- PR Newswire
USANA Cements Itself as a Premier Cellular Nutrition Company in South Korea
USANA Health Sciences, a global cellular nutrition company, was recently recognized at the prestigious Korea Medical Healthcare Awards in the multivitamin category for the sixth consecutive year and the weight management category for the fourth consecutive year.
- CNW Group
Kevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024
As the business world evolves at an unprecedented rate, the need for individuals who possess a robust growth mindset has never been more critical. Recent findings underscore that companies fostering a culture of continuous learning and adaptability outperform their competitors significantly.
